FDA Orange Book
Generic for Revatio
Revatio contains sildenafil. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Revatio is sildenafil. 18 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AP.
Run it in Rivvi
Map Revatio and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Revatio products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| for suspension, oral | EQ 10MG BASE/ML | Discontinued | None | 11 | AB |
| solution, intravenous | EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) | Marketed (Rx) | AP | 1 | AP |
| tablet, oral | EQ 20MG BASE | Marketed (Rx) | AB | 10 | AB |
NDA 203109, 022473, 021845, held by VIATRIS SPECIALTY LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic sildenafil
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| CHARTWELL RX SCIENCES LLC | 202598 | AB (A-rated, therapeutically equivalent) | November 6, 2012 | EQ 20MG BASE |
| TORRENT PHARMACEUTICALS LTD | 091479 | AB (A-rated, therapeutically equivalent) | November 6, 2012 | EQ 20MG BASE |
| WATSON LABORATORIES INC | 202503 | AB (A-rated, therapeutically equivalent) | November 6, 2012 | EQ 20MG BASE |
| AMNEAL PHARMACEUTICALS | 202025 | AB (A-rated, therapeutically equivalent) | February 28, 2013 | EQ 20MG BASE |
| MACLEODS PHARMACEUTICALS LTD | 203814 | AB (A-rated, therapeutically equivalent) | December 17, 2013 | EQ 20MG BASE |
| HETERO LABS LTD UNIT V | 203623 | AB (A-rated, therapeutically equivalent) | November 26, 2014 | EQ 20MG BASE |
| EUGIA PHARMA SPECIALITIES LTD | 203988 | AP (A-rated, therapeutically equivalent) | April 1, 2015 | EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) |
| AUROBINDO PHARMA LTD | 203963 | AB (A-rated, therapeutically equivalent) | November 18, 2015 | EQ 20MG BASE |
| RUBICON RESEARCH LTD | 204883 | AB (A-rated, therapeutically equivalent) | June 20, 2016 | EQ 20MG BASE |
| AJANTA PHARMA LTD | 210394 | AB (A-rated, therapeutically equivalent) | May 4, 2018 | EQ 20MG BASE |
| NOVITIUM PHARMA LLC | 212260 | AB (A-rated, therapeutically equivalent) | May 31, 2019 | EQ 10MG BASE/ML |
| AJANTA PHARMA LTD | 212883 | AB (A-rated, therapeutically equivalent) | November 27, 2019 | EQ 10MG BASE/ML |
| ALKEM LABORATORIES LTD | 212440 | AB (A-rated, therapeutically equivalent) | November 27, 2019 | EQ 10MG BASE/ML |
| AMNEAL PHARMACEUTICALS OF NEW YORK LLC | 211092 | AB (A-rated, therapeutically equivalent) | November 27, 2019 | EQ 10MG BASE/ML |
| TEVA PHARMACEUTICALS USA | 211534 | AB (A-rated, therapeutically equivalent) | May 29, 2020 | EQ 10MG BASE/ML |
| INVAGEN PHARMACEUTICALS INC | 213041 | AB (A-rated, therapeutically equivalent) | August 6, 2020 | EQ 10MG BASE/ML |
| CHARTWELL RX SCIENCES LLC | 213814 | AB (A-rated, therapeutically equivalent) | April 29, 2021 | EQ 10MG BASE/ML |
| HETERO LABS LTD UNIT V | 213014 | AB (A-rated, therapeutically equivalent) | May 11, 2021 | EQ 10MG BASE/ML |
| MSN LABORATORIES PRIVATE LTD | 214641 | AB (A-rated, therapeutically equivalent) | February 8, 2022 | EQ 10MG BASE/ML |
| ZYDUS LIFESCIENCES GLOBAL FZE | 215708 | AB (A-rated, therapeutically equivalent) | September 29, 2022 | EQ 10MG BASE/ML |
| AUROBINDO PHARMA LTD | 214773 | AB (A-rated, therapeutically equivalent) | December 23, 2022 | EQ 10MG BASE/ML |
| JUBILANT GENERICS LTD | 202954 | AB (A-rated, therapeutically equivalent) | March 6, 2025 | EQ 20MG BASE |
Revatio exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| M-287 | Miscellaneous | January 31, 2026 | 203109 |
| ODE-469 | Orphan drug exclusivity | January 31, 2030 | 021845 |
Revatio NDC codes
Questions
Is there a generic for Revatio?
Yes. The generic name for Revatio is sildenafil. 18 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AP.
What is the generic name for Revatio?
The active ingredient in Revatio is sildenafil, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Revatio and Sildenafil
- What is Sildenafil used for?FDA label uses
- Is Sildenafil a controlled substance?Federal schedule
- Generic for VybriqueFDA Orange Book
- Generic for ViagraFDA Orange Book
- Phosphodiesterase 5 Inhibitors listFDA drug class
- NDC 0069-4190Revatio NDC record
- NDC 58151-385Revatio NDC record
- NDC 58151-395Revatio NDC record